Professional Documents
Culture Documents
Product catalog No: 2523800
ReaPan B27
Manufactured by
2
ReaPan B27
1. INTENDED USE
Human Leukocyte Antigen B27, a class I surface antigen encoded by the
B locus in the major histocompatibility complex (MHC) presents
microbial antigens to TLymphocytes. The onset of seronegative
spondyloarthropathies that includes ankylosing spondylitis, Reiter’s
disease, psoriatic arthritis and inflammatory bowel disease (1,2,3,4) is
associated with the expression of HLAB27 antigen on TLymphocytes.
Screening for HLAB27 is thus of clinical relevance in conjunction with
the symptomatic presentation of the disorder. Microlymphotoxicity tests
are conventionally used in HLAtyping but are typically timeconsuming
and expensive. Flow cytometry has gradually evolved into a faster and
reliable method for screening samples for HLAB27 antigen (5,6).
4
3. PRINCIPLES OF THE PROCEDURE
Tlymphocytes selected through gating of CD3 specific populations are
analyzed for staining by HLAB27 conjugates. It has been demonstrated
that the preselection of TLymphocytes increases the specificity of the
test by eliminating the background caused from other leukocyte
populations (8). Another method to reduce falsepositives is by the
addition of antiB7 antibody to the reagent cocktail. The antiB7 antibody
competes with the B27 antibody for the B7 antigen and in this manner
suppresses the incidence of crossreactivity of antiB27 antibodies to B7
antigens (1).
The ReaMetrix reagent for HLAB27 typing improves the specificity by
having two clones of the antiHLAB27 antibody and an antibody against
the B7 antigen. By having two clones, multiple epitopic regions of the
B27 antigen are targeted ensuring that more B27 antigens are identified.
The antiB7 antibody binds preferentially to the B7 antigen thereby
reducing crossreactivity.
5
The test result is a direct extrapolation of the fluorescent staining
intensity of the HLAB27 conjugates with respect to a cutoff value.
4. REAGENT
The ReaPan B27 reagent is formulated in buffered saline with sodium
azide and stabilizers. It contains RPhycoerythrin (PE) – labeled
monoclonal AntiHLAB27 antibodies (clones FD705 and HLAABCm3),
PEDyomics649 – labeled AntiCD3 monoclonal antibody (clone UCHT1)
and unlabeled AntiB7 antibody (clone BB7.1) (1,7). A precise number of
fluorescent beads are included to facilitate internal calibration of the
reagent and determine RMX value. The ReaPan B27 reagent is provided
as a readytouse test, dried down in flow cytometer compatible sample
tubes.
Precautions
1. Warning: The ReaPan B27 reagent contains Sodium azide.
Sodium azide is harmful if swallowed. Wear suitable protective
6
clothing. If swallowed, seek medical advice immediately. Contact
with acids liberates toxic gas. Azides should be flushed with
large amounts of water during disposal to avoid deposits in lead
or copper plumbing.
2. Warning: All blood specimens are considered biohazards.
Handle them as if they are capable of transmitting infection and
dispose off with proper precautions in accordance with
governmental regulations.
3. The addition of the precise volume of blood is critical to obtain
correct results. Use a calibrated pipette and operate according
to the manufacturer’s instructions.
4. The ReaPan B27 reagent and the control beads are in dried
form. It is absolutely critical to ensure vigorous vortexing after
addition of blood sample to ensure solubilization of the reagent
and the beads.
Storage and Handling
1. Store the reagent at room temperature in a dry place. Do not
use the reagent after the expiry date on the label.
7
2. Do not freeze the ReaPan B27.
3. The ReaPan B27 reagent is light sensitive. Do not expose to
direct light either during storage or when mixed with blood.
3. INSTRUMENT
The ReaPan B27 reagent has been tested on the FACScan™ and
FACSCalibur™ systems manufactured by BectonDickinson. ReaMetrix
recommends running this reagent on these instruments. The instrument
should be calibrated for setting photomultiplier tube voltages,
fluorescence compensation, and checking instrument sensitivity
according to the manufacturer’s guidelines.
4. SPECIMEN COLLECTION
The anticoagulated blood must be stored at room temperature (20°C
25°C) and should be stained and analyzed ideally within 24 hours of
draw.
Important!
5. PROCEDURE
Reagent Provided
ReaPan B27 reagent
Reagents and materials required but not provided
1. Blood collection tube
2. Calibrated pipettes
3. Vortex mixer
9
4. ReaLyse Solution
5. Sheath fluid (BD FACSFlow™ Catalog No. 340398 or
equivalent)
6. Calibrite Beads
Assay Protocol
10
Flow Cytometer Acquisition and Analysis
This protocol assumes that the flow cytometer has been setup according
to the manufacturer’s instructions (For example, In the case of
FACScan™, the instrument should be setup and calibrated using
CaliBrite™ beads and FACSComp™ software). Open the CellQuest™
Pro software and connect to the cytometer.
The fluorescence filters referred to in the subsequent sections are given
below:
• FL1 – 530 ± 30 nm
• FL2 – 585 ± 42 nm
• FL3 – 670 nm LP (BD FACS Calibur™) or 650 nm LP (BD
FACScan™)
Open a new document (File>New document) and select the option to
view instrument settings:
11
• Set the compensation settings on all channels to
zero
• Set the threshold on FL3
• Set Intensity to Channel values (CellQuest Pro
toolbar>Plots>Log Data Units>Channel Values)
1. Draw two dotplot (View1 and View2) and four histogram (View
3,
View4, View5, View6) views –
• View1 (Dot Plot): CD3 PEDy649 fluorescence (FL3)
versus side scatter (SSC – Linear scale).
• View2 (Dot Plot): FL2 versus FL1 of events gated as
beads from the first view to capture the fluorescent reference
beads. The beads have a high FL1 and FL2 Fluorescence
Intensity
• View3 (Histogram): HLAB27PE fluorescence (FL2)
versus counts of events gated as CD3 positive (R1) from
View1.
12
• View4, View5, and View6 (Histogram): Fluorescent
bead intensity (on FL1, FL2 & FL3) obtained from R3 of View
2 versus Counts.
• Set the number of events to capture at 4000 for R3
gate (View 2) before data acquisition. When 4000 beads are
acquired in the gate, acquisition stops.
• Select the histogram statistics option for View3, View4
and View5 & View6
2. Adjust the Sidescatter and FL3 voltage settings on View 1 to
acquire CD3 positive (R1) and bead populations (R2) as
shown. Ensure that both the beads and the lymphocyte
populations are acquired and can be visualized as separate
from the background.(Note: Multicolored gating can be used
to prevent unintentional thresholding out beads)
3. Adjust the FL2 voltage settings to position R3 gated beads to
600±10 channels (Histogram stats – M1 – Median
Fluorescence Intensity) on View
13
4. Similarly adjust FL1 and FL3 voltage gain to set the R3 gated
beads on FL1 at a MdFI of 600±10 and 400±10 channels
respectively. (The above steps are critical for the accuracy of
the test results and must not be skipped)
5. Obtain the R1gated HLAB27 population on View 3 to record
the fluorescence intensity on histogram stats (of all events).
6. Enter the K value for the particular batch of reagent from the
label on the pouch and calculate RMX value as shown.
MdFIsample – K x MdFIbeads on FL2
RMX Value* =
MdFIbeads on FL2
*K is a constant unique to each reagent lot given on the Reagent Pouch Label
If RMX Value ≤0, then sample is HLA B27 negative
If RMX Value >0, then sample is HLA B27 positive
14
View 1 View 2
Dot plot views: View1: CD3PEDy649 fluorescence (FL3 log scale) versus sidescatter
(SSC – Linear scale) to capture CD3+ (R1) and fluorescence beads (R2) View2: FL1
versus FL2 (both on log scale) and R2 gate applied to obtain a clean reference beads
population (R3)
15
View 3
16
6. LIMITATIONS
1. The ReaPan B27 reagent has only been validated with K 3EDTA
treated whole blood.
2. It is the responsibility of the user to ensure that the flow cytometer
instrument is calibrated according to manufacturer’s instructions.
3. It is important that the gain settings are adjusted to position the
fluorescent beads as described in Section 6.0. The R1 gate must be
visually checked to ensure adequate Tlymphocyte gating.
4. The test result bears a direct relation to the intensity of the
Phycoerythrin (PE) in the reagent. Exposure of reagent to direct light
or use of expired reagents may prove detrimental to the accuracy of
the test results.
5 The HLAB27 test result is not indicative of the presence or absence
of a disease condition. HLAB27 expression along with symptomatic
presentation and clinical history of the patient should be carefully
considered by the physician in making a diagnosis (7).
17
7. WARRANTY
This product is warranted only to conform to the quantity and contents
stated on the label at the time of delivery to the customer. There are no
warranties, expressed or implied, that extend beyond the description on
the label of the product. ReaMetrix’s sole liability is limited to
replacement of the product. Reametrix is not liable for property damage,
personal injury, or economic loss caused by the product.
Note: FACScan, CaliBRITE, FACSLyse, FACSComp, FACSCalibur are all
registered trade names of BectonDickinson.
8. REFERENCES
1. Wilfried H. B. M. Levering, Henk Wind, Kees Sintnicolaas, Herbert
Hooijkaas, and Jan W. Gratama. Flow Cytometric HLAB27
Screening: CrossReactivityPatterns of Commercially Available Anti–
HLAB27 Monoclonal Antibodies With Other HLAB Antigens.
Cytometry Part B (Clinical Cytometry) 54B:28–38 (2003)
18
2. Michael J. Warzynski. HLAB27 TESTING: MEAN CHANNELS, QC,
AND SURVEYS. Cytometry (Communications in Clinical Cytometry)
30:208–211 (1997)
5. Michael T. Seipp, Maria Erali, Rae Lynn Wies, and Carl Wittwer. HLA
B27 Typing: Evaluation of an AlleleSpecific PCR Melting Assay and
Two Flow Cytometric Antigen Assays. Cytometry Part B (Clinical
Cytometry) 63B:10–15 (2005)
19
6. W.H.B.M. Levering, H. Wind, H. Hooijkaas, K. Sintnicolaas, B.
Brando, J.W. Gratama. Flow cytometric screening for HLAB27 on
peripheral blood lymphocytes. J Biol Regul Homeost Agents 2003;
17: 2416
9. Wendy M. Reynolds, Philip R. Evans, Andrew C. Lane, W. Martin
Howell, Peter J. Wilson, Raymond Wong, and John L. Smith
Automated HLAB27 Testing Using the FACSPrep/FACScan
System. Cytometry (Communications in Clinical Cytometry) 18: 109
1 15 (1994)
20
10. Wilfried Levering External quality assessment in flow cytometry.
Educational aspects and trends toward improvement. Doctoral
Thesis
11. Wilfried H.B.M. Levering, Rene van den Beemd, Jeroen G. te Marvelde,
Wil A.M. van Beers, Herbert Hooijkaas, Kees Sintnicolaas, and Jan W.
Gratama. External Quality Assessment of Flow Cytometric HLAB27
Typing. Cytometry (Communications in Clinical Cytometry) 42:95–105
(2000)
21
Manufactured by ReaMetrix India Pvt. Ltd.
50B, II Phase, Peenya Industrial Area
Peenya, Bangalore 560058, India
22
Ph: +918028378693/5, Fax: +918041172451
Email: info@reametrix.com
www.reametrix.com
Rev No. 2.0, 21Apr09
23